- Home
- TLSI vs ARBE Comparison
TLSI vs ARBE Comparison
Compare TLSI & ARBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- ARBE
- Stock Information
- Founded
- TLSI 2010
- ARBE 2015
- Country
- TLSI United States
- ARBE Israel
- Employees
- TLSI N/A
- ARBE N/A
- Industry
- TLSI Medical Specialities
- ARBE EDP Services
- Sector
- TLSI Health Care
- ARBE Technology
- Exchange
- TLSI Nasdaq
- ARBE Nasdaq
- Market Cap
- TLSI 204.0M
- ARBE 203.2M
- IPO Year
- TLSI N/A
- ARBE N/A
- Fundamental
- Price
- TLSI $4.56
- ARBE $1.56
- Analyst Decision
- TLSI Strong Buy
- ARBE Buy
- Analyst Count
- TLSI 5
- ARBE 2
- Target Price
- TLSI $10.90
- ARBE $1.75
- AVG Volume (30 Days)
- TLSI 134.8K
- ARBE 1.5M
- Earning Date
- TLSI 08-13-2025
- ARBE 08-07-2025
- Dividend Yield
- TLSI N/A
- ARBE N/A
- EPS Growth
- TLSI N/A
- ARBE N/A
- EPS
- TLSI N/A
- ARBE N/A
- Revenue
- TLSI $32,141,000.00
- ARBE $671,000.00
- Revenue This Year
- TLSI $55.39
- ARBE $285.16
- Revenue Next Year
- TLSI $54.89
- ARBE $370.11
- P/E Ratio
- TLSI N/A
- ARBE N/A
- Revenue Growth
- TLSI 46.20
- ARBE N/A
- 52 Week Low
- TLSI $3.50
- ARBE $0.85
- 52 Week High
- TLSI $6.04
- ARBE $5.09
- Technical
- Relative Strength Index (RSI)
- TLSI 39.21
- ARBE 48.15
- Support Level
- TLSI $4.41
- ARBE $1.44
- Resistance Level
- TLSI $4.73
- ARBE $1.67
- Average True Range (ATR)
- TLSI 0.22
- ARBE 0.09
- MACD
- TLSI -0.02
- ARBE -0.01
- Stochastic Oscillator
- TLSI 18.99
- ARBE 40.98
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.